Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
4.000
-0.320 (-7.41%)
At close: Oct 9, 2026, 4:00 PM EDT
3.400
-0.600 (-15.00%)
After-hours: Oct 9, 2026, 7:43 PM EDT
Niki BioSolutions Employees
Niki BioSolutions had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Niki BioSolutions the 43,919th largest employer in the world and 7,263rd in the United States.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,247,494
Market Cap
11.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | -2 | -66.67% | 1 | 0 |
| Dec 31, 2023 | 3 | -16 | -84.21% | 3 | 0 |
| Dec 31, 2022 | 19 | -7 | -26.92% | 18 | 1 |
| Dec 31, 2021 | 26 | 0 | - | 26 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 113 |
| CytoMed Therapeutics | 42 |
| Cerenome | 28 |
| BioLineRx | 24 |
| Passage Bio | 24 |
| Daré Bioscience | 24 |
| Citius Pharmaceuticals | 23 |
| Cellectar Biosciences | 11 |
NIKI News
- 15 days ago - Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference - GlobeNewsWire
- 26 days ago - Niki BioSolutions Accelerates Its Alzheimer's Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics - GlobeNewsWire
- 4 weeks ago - Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - Niki BioSolutions files $75M mixed securities shelf - TheFly
- 2 months ago - Aptorum Group Provides Update on DiamiR Biosciences Merger - GlobeNewsWire
- 3 months ago - Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer's Association International Conference - GlobeNewsWire
- 3 months ago - Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers - GlobeNewsWire
- 3 months ago - Statement in Response to Silver Elephant's News Release Dated June 17, 2026 - Newsfile Corp